FHIR IG analytics| Package | hl7.fhir.uv.xver-r4.r5 |
| Resource Type | ValueSet |
| Id | ValueSet-R4-resource-types-for-R5.json |
| FHIR Version | R5 |
| Source | http://hl7.org/fhir/uv/xver-r4.r5/0.1.0/ValueSet-R4-resource-types-for-R5.html |
| URL | http://hl7.org/fhir/uv/xver/ValueSet/R4-resource-types-for-R5 |
| Version | 0.1.0 |
| Status | active |
| Date | 2026-03-17T21:02:03.8104715+00:00 |
| Name | R4ResourceTypesForR5 |
| Title | Cross-version ValueSet R4.ResourceType for use in FHIR R5 |
| Realm | uv |
| Authority | hl7 |
| Description | This cross-version ValueSet represents content from http://hl7.org/fhir/ValueSet/resource-types|4.0.1 for use in FHIR R5 that is appropriate for use but unavailable in `http://hl7.org/fhir/ValueSet/resource-types|5.0.0`. |
| Purpose | This value set is part of the cross-version definitions generated to enable use of the value set `http://hl7.org/fhir/ValueSet/resource-types|4.0.1` as defined in FHIR R4 in FHIR R5. The source value set is bound to the following FHIR R4 elements: * `CapabilityStatement.rest.resource.type` as Required * `CompartmentDefinition.resource.code` as Required * `ExampleScenario.instance.resourceType` as Required * `GraphDefinition.link.target.type` as Required * `GraphDefinition.start` as Required * `ImplementationGuide.global.type` as Required * `MessageDefinition.focus.code` as Required * `OperationDefinition.resource` as Required * `Questionnaire.subjectType` as Required * `Reference.type` as Extensible * `SearchParameter.base` as Required * `SearchParameter.target` as Required Across FHIR versions, the value set has been mapped as: * `http://hl7.org/fhir/ValueSet/resource-types|4.0.1` * `http://hl7.org/fhir/ValueSet/resource-types|4.3.0` * `http://hl7.org/fhir/ValueSet/resource-types|5.0.0` Note that there are 132 concepts not included in this cross-version definition because they have valid representations. Following are the generation technical comments: The source value set has more active concepts (148) than the target (143), so the source is broader than the target. One or more source concepts are either not mapped or broader than their targets, so the value set relationship is broadened. The source value set has fewer active concepts (143) than the target (158), so the source is narrower than the target. |
| StructureDefinition | ||
| hl7.fhir.uv.xver-r4.r5#0.1.0 | extension-GraphDefinition.link.target | R4: Potential target for the link (new) |
| hl7.fhir.uv.xver-r4.r5#0.1.0 | extension-GraphDefinition.link | R4: link |
| CodeSystem | ||
| dk.ehealth.sundhed.fhir.ig.core#current | resource-types | Resource Type |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet R4-resource-types-for-R5
This value set expansion contains 17 concepts.
| System | Version | Code | Display | Definition |
http://hl7.org/fhir/resource-types | 4.0.1 | EffectEvidenceSynthesis | EffectEvidenceSynthesis | The EffectEvidenceSynthesis resource describes the difference in an outcome between exposures states in a population where the effect estimate is derived from a combination of research studies. |
http://hl7.org/fhir/resource-types | 4.0.1 | Media | Media | A photo, video, or audio recording acquired or used in healthcare. The actual content may be inline or provided by direct reference. |
http://hl7.org/fhir/resource-types | 4.0.1 | MedicinalProductAuthorization | MedicinalProductAuthorization | The regulatory authorization of a medicinal product. |
http://hl7.org/fhir/resource-types | 4.0.1 | MedicinalProductContraindication | MedicinalProductContraindication | The clinical particulars - indications, contraindications etc. of a medicinal product, including for regulatory purposes. |
http://hl7.org/fhir/resource-types | 4.0.1 | MedicinalProductIndication | MedicinalProductIndication | Indication for the Medicinal Product. |
http://hl7.org/fhir/resource-types | 4.0.1 | MedicinalProductIngredient | MedicinalProductIngredient | An ingredient of a manufactured item or pharmaceutical product. |
http://hl7.org/fhir/resource-types | 4.0.1 | MedicinalProductInteraction | MedicinalProductInteraction | The interactions of the medicinal product with other medicinal products, or other forms of interactions. |
http://hl7.org/fhir/resource-types | 4.0.1 | MedicinalProductManufactured | MedicinalProductManufactured | The manufactured item as contained in the packaged medicinal product. |
http://hl7.org/fhir/resource-types | 4.0.1 | MedicinalProductPackaged | MedicinalProductPackaged | A medicinal product in a container or package. |
http://hl7.org/fhir/resource-types | 4.0.1 | MedicinalProductPharmaceutical | MedicinalProductPharmaceutical | A pharmaceutical product described in terms of its composition and dose form. |
http://hl7.org/fhir/resource-types | 4.0.1 | MedicinalProductUndesirableEffect | MedicinalProductUndesirableEffect | Describe the undesirable effects of the medicinal product. |
http://hl7.org/fhir/resource-types | 4.0.1 | RiskEvidenceSynthesis | RiskEvidenceSynthesis | The RiskEvidenceSynthesis resource describes the likelihood of an outcome in a population plus exposure state where the risk estimate is derived from a combination of research studies. |
http://hl7.org/fhir/resource-types | 4.0.1 | SubstanceNucleicAcid | SubstanceNucleicAcid | Nucleic acids are defined by three distinct elements: the base, sugar and linkage. Individual substance/moiety IDs will be created for each of these elements. The nucleotide sequence will be always entered in the 5’-3’ direction. |
http://hl7.org/fhir/resource-types | 4.0.1 | SubstancePolymer | SubstancePolymer | Todo. |
http://hl7.org/fhir/resource-types | 4.0.1 | SubstanceProtein | SubstanceProtein | A SubstanceProtein is defined as a single unit of a linear amino acid sequence, or a combination of subunits that are either covalently linked or have a defined invariant stoichiometric relationship. This includes all synthetic, recombinant and purified SubstanceProteins of defined sequence, whether the use is therapeutic or prophylactic. This set of elements will be used to describe albumins, coagulation factors, cytokines, growth factors, peptide/SubstanceProtein hormones, enzymes, toxins, toxoids, recombinant vaccines, and immunomodulators. |
http://hl7.org/fhir/resource-types | 4.0.1 | SubstanceReferenceInformation | SubstanceReferenceInformation | Todo. |
http://hl7.org/fhir/resource-types | 4.0.1 | SubstanceSourceMaterial | SubstanceSourceMaterial | Source material shall capture information on the taxonomic and anatomical origins as well as the fraction of a material that can result in or can be modified to form a substance. This set of data elements shall be used to define polymer substances isolated from biological matrices. Taxonomic and anatomical origins shall be described using a controlled vocabulary as required. This information is captured for naturally derived polymers ( . starch) and structurally diverse substances. For Organisms belonging to the Kingdom Plantae the Substance level defines the fresh material of a single species or infraspecies, the Herbal Drug and the Herbal preparation. For Herbal preparations, the fraction information will be captured at the Substance information level and additional information for herbal extracts will be captured at the Specified Substance Group 1 information level. See for further explanation the Substance Class: Structurally Diverse and the herbal annex. |
FHIR
FHIRsmith{
"resourceType": "ValueSet",
"id": "R4-resource-types-for-R5",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 5
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "fhir"
},
{
"extension": [
{
"url": "packageId",
"valueId": "hl7.fhir.uv.xver-r4.r5"
},
{
"url": "version",
"valueString": "0.1.0"
},
{
"url": "uri",
"valueUri": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r4.r5"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/package-source"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/uv/xver/ImplementationGuide/hl7.fhir.uv.xver-r4.r5"
}
]
}
}
],
"url": "http://hl7.org/fhir/uv/xver/ValueSet/R4-resource-types-for-R5",
"version": "0.1.0",
"name": "R4ResourceTypesForR5",
"title": "Cross-version ValueSet R4.ResourceType for use in FHIR R5",
"status": "active",
"experimental": false,
"date": "2026-03-17T21:02:03.8104715+00:00",
"publisher": "FHIR Infrastructure",
"contact": [
{
"name": "FHIR Infrastructure",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/fiwg"
}
]
}
],
"description": "This cross-version ValueSet represents content from http://hl7.org/fhir/ValueSet/resource-types|4.0.1 for use in FHIR R5 that is appropriate for use but unavailable in `http://hl7.org/fhir/ValueSet/resource-types|5.0.0`.",
"jurisdiction": [
{
"coding": [
{
"system": "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code": "001",
"display": "World"
}
]
}
],
"purpose": "This value set is part of the cross-version definitions generated to enable use of the\r\nvalue set `http://hl7.org/fhir/ValueSet/resource-types|4.0.1` as defined in FHIR R4\r\nin FHIR R5.\r\n\r\nThe source value set is bound to the following FHIR R4 elements:\r\n* `CapabilityStatement.rest.resource.type` as Required\n* `CompartmentDefinition.resource.code` as Required\n* `ExampleScenario.instance.resourceType` as Required\n* `GraphDefinition.link.target.type` as Required\n* `GraphDefinition.start` as Required\n* `ImplementationGuide.global.type` as Required\n* `MessageDefinition.focus.code` as Required\n* `OperationDefinition.resource` as Required\n* `Questionnaire.subjectType` as Required\n* `Reference.type` as Extensible\n* `SearchParameter.base` as Required\n* `SearchParameter.target` as Required\r\n\r\nAcross FHIR versions, the value set has been mapped as:\r\n* `http://hl7.org/fhir/ValueSet/resource-types|4.0.1`\n* `http://hl7.org/fhir/ValueSet/resource-types|4.3.0`\n* `http://hl7.org/fhir/ValueSet/resource-types|5.0.0`\r\n\r\nNote that there are 132 concepts not included in this cross-version definition because they have valid representations.\r\n\r\nFollowing are the generation technical comments:\r\nThe source value set has more active concepts (148) than the target (143), so the source is broader than the target.\nOne or more source concepts are either not mapped or broader than their targets, so the value set relationship is broadened.\nThe source value set has fewer active concepts (143) than the target (158), so the source is narrower than the target.",
"compose": {
"include": [
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"concept": [
{
"code": "EffectEvidenceSynthesis",
"display": "EffectEvidenceSynthesis"
},
{
"code": "Media",
"display": "Media"
},
{
"code": "MedicinalProductAuthorization",
"display": "MedicinalProductAuthorization"
},
{
"code": "MedicinalProductContraindication",
"display": "MedicinalProductContraindication"
},
{
"code": "MedicinalProductIndication",
"display": "MedicinalProductIndication"
},
{
"code": "MedicinalProductIngredient",
"display": "MedicinalProductIngredient"
},
{
"code": "MedicinalProductInteraction",
"display": "MedicinalProductInteraction"
},
{
"code": "MedicinalProductManufactured",
"display": "MedicinalProductManufactured"
},
{
"code": "MedicinalProductPackaged",
"display": "MedicinalProductPackaged"
},
{
"code": "MedicinalProductPharmaceutical",
"display": "MedicinalProductPharmaceutical"
},
{
"code": "MedicinalProductUndesirableEffect",
"display": "MedicinalProductUndesirableEffect"
},
{
"code": "RiskEvidenceSynthesis",
"display": "RiskEvidenceSynthesis"
},
{
"code": "SubstanceNucleicAcid",
"display": "SubstanceNucleicAcid"
},
{
"code": "SubstancePolymer",
"display": "SubstancePolymer"
},
{
"code": "SubstanceProtein",
"display": "SubstanceProtein"
},
{
"code": "SubstanceReferenceInformation",
"display": "SubstanceReferenceInformation"
},
{
"code": "SubstanceSourceMaterial",
"display": "SubstanceSourceMaterial"
}
]
}
]
},
"expansion": {
"timestamp": "2026-03-17T21:02:03.8104715+00:00",
"contains": [
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "EffectEvidenceSynthesis",
"display": "EffectEvidenceSynthesis"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "Media",
"display": "Media"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "MedicinalProductAuthorization",
"display": "MedicinalProductAuthorization"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "MedicinalProductContraindication",
"display": "MedicinalProductContraindication"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "MedicinalProductIndication",
"display": "MedicinalProductIndication"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "MedicinalProductIngredient",
"display": "MedicinalProductIngredient"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "MedicinalProductInteraction",
"display": "MedicinalProductInteraction"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "MedicinalProductManufactured",
"display": "MedicinalProductManufactured"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "MedicinalProductPackaged",
"display": "MedicinalProductPackaged"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "MedicinalProductPharmaceutical",
"display": "MedicinalProductPharmaceutical"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "MedicinalProductUndesirableEffect",
"display": "MedicinalProductUndesirableEffect"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "RiskEvidenceSynthesis",
"display": "RiskEvidenceSynthesis"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "SubstanceNucleicAcid",
"display": "SubstanceNucleicAcid"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "SubstancePolymer",
"display": "SubstancePolymer"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "SubstanceProtein",
"display": "SubstanceProtein"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "SubstanceReferenceInformation",
"display": "SubstanceReferenceInformation"
},
{
"system": "http://hl7.org/fhir/resource-types",
"version": "4.0.1",
"code": "SubstanceSourceMaterial",
"display": "SubstanceSourceMaterial"
}
]
}
}